DNA and RNA aptamers can power portable biosensors that detect viruses within minutes, with potential uses beyond clinical ...
Hummingbird Diagnostics GmbH, a pioneer in leveraging blood-based small RNA diagnostics for early cancer detection and characterization with an initial focus on lung cancer, today announced the ...
Financing accelerates clinical validation and commercial readiness, as circular RNAs emerge as a new category of brain-derived blood biomarkers with best-in-class performance SAN DIEGO, Dec. 1, 2025 ...
Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...
RNA Drugs: presented yesterday in Naples, at the research area of Naples of the CNR, in via Pietro Castellino, the results of ...
Hosted on MSN
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...
Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...
Liquid biopsies are tests that detect signs of cancer through a simple blood draw. Unlike traditional biopsies, which require removing a piece of tissue, a liquid biopsy typically looks for mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback